Skip to main content
Fig. 3 | Journal of Experimental & Clinical Cancer Research

Fig. 3

From: Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy

Fig. 3

Quantitative western blot analysis for modulation of immune-related proteins in melanoma cell lines by epigenetic drugs. Eleven melanoma cell lines were treated with guadecitabine (GUA), givinostat (GIV), JQ1, OTX-015 (OTX), GSK-126 (GSK) and abemaciclib (ABEMA) and assessed for expression/modulation of 14 proteins. Data analysis and visualization approach described in Suppl. Fig. S12 and S13. Grey boxes: the antigen was not expressed and not induced by treatments

Back to article page